about
Cytokine responses during chronic denervation.Anoctamin 2 identified as an autoimmune target in multiple sclerosisMHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarctionThe expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosisA/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation.High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisSystemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variantsComplement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.γ-Secretase directly sheds the survival receptor BCMA from plasma cellsPro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls.Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and miceIntravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationNeurofascin as a target for autoantibodies in peripheral neuropathies.Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteinsAutoantibody profiling in multiple sclerosis using arrays of human protein fragments.Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis.Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block.Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.Autoantibody targets in vaccine-associated narcolepsy.Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
P50
Q24815947-DD93D407-E0FE-48BB-92D0-DF5D3940F328Q28273167-3DEB1174-9876-42A4-B36D-DAEE12D510E8Q28581447-E0B619E9-3CDE-401D-A451-5EBAAA68E687Q28740407-630B1A14-6482-471B-B69D-3F23EEF6033EQ30358564-C76DD4F4-2B4E-4DEA-883A-4477FBF4D154Q30371742-CE95CCD1-F49F-46B0-A01E-891F82B1480BQ33490992-78A86B07-975A-48BC-B8FB-24F810997F69Q34279465-88BD1F7F-DB27-480D-8FF5-FE3F3446A13FQ34395141-05964F5E-CD21-4E65-9A24-96D227342BEEQ34524908-A13BC406-038B-4C2C-846E-ED6BD2AA098EQ34613311-1DCF0DDD-2446-4D56-9099-47900EC4D5E1Q34643537-CE6EE6C7-8C07-4A29-9185-DD45BC3A2F13Q34718044-D9BCC561-33E9-448F-ACC5-780EB8DFE1AEQ34810293-541228EE-1FD2-4C55-A87D-045BD483CEDFQ34975529-A563B262-3A90-4C65-A40D-02A7433568F7Q35157207-7B471BF7-8578-4775-A175-7580902E1978Q35250966-BA504405-34BB-46A0-AA4B-2B9F1C7BD28CQ35549328-721ABCDA-B3DB-4A60-A2D0-0AE7342491C9Q35814239-AE9AFDCC-A751-4CBB-9EED-DC151884D247Q35873009-91033883-0D04-4E1F-B1A4-5CC5C7A42BDCQ35907536-F6598DE9-78F3-4A0F-96FE-FD8D60838546Q36029291-7BBD640A-C990-4F5D-AB97-DCCF09F7D02BQ36140339-70A3FEDF-5D21-429D-897C-D7CF1AA4BC0CQ36298920-EC391195-A73E-40D0-A7B0-90A12B55016CQ36451661-DADA228C-4049-49A2-B556-544EBDEAFC61Q36524437-4EEBD004-9908-4BA1-888D-67F3B392CA2FQ37058064-429FD185-26E0-4070-80D9-3F78DDCB4DCDQ37102527-90BAE08C-AEFE-41E4-B502-E5F02CCD35A8Q37160963-C8DC881C-0DE1-483B-BCB5-15199AE08582Q37196796-4E45E2B0-708F-4377-AB5F-A338021A7B37Q37222038-162EEA7B-B1FE-43BA-9F6D-02690A297887Q38368984-B1CFBC4F-9C1A-4A63-87CB-30B3820DF60CQ39499696-E4D03A81-CD8A-4B2C-91C4-D05E227A893AQ39669309-75A6CAD8-E130-4E2A-8091-FC8B9196F005Q39808939-22D17049-67EE-44D5-B471-7DC04818349FQ40743940-EDDD0E11-3A01-4BFE-87F4-5E3BD7BEEFE8Q41422799-71E100FA-5294-482D-9FC5-9DDDD034AB7BQ42453933-CE39C80C-ED78-4711-A0B3-6D9C26910939Q43227358-DDF17E16-4AF8-4D78-A131-B8107D551CCAQ43502571-E6714919-E1D7-496D-B784-65302C64C493
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mohsen Khademi
@ast
Mohsen Khademi
@en
Mohsen Khademi
@es
Mohsen Khademi
@nl
Mohsen Khademi
@sl
type
label
Mohsen Khademi
@ast
Mohsen Khademi
@en
Mohsen Khademi
@es
Mohsen Khademi
@nl
Mohsen Khademi
@sl
prefLabel
Mohsen Khademi
@ast
Mohsen Khademi
@en
Mohsen Khademi
@es
Mohsen Khademi
@nl
Mohsen Khademi
@sl
P106
P21
P31
P496
0000-0003-0801-1444